p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The mechanisms by which p53 prevents development of cancer are much more complicated than previously thought. Under normal conditions, p53 is involved in cell-cycle arrest, Q1apoptosis, DNA repair, and inhibition of angiogenesis; it also promotes degradation of proteins through transcriptional regulation of certain target genes. Here we report the isolation of a novel transcriptional target of p53, designated p53RFP (p53-inducible RING-finger protein), whose product has E3 ubiquitin ligase activity. Its expression was negatively correlated to that of p21(WAF1) protein; p53RFP is likely to play a role in the regulation of this protein, probably through interaction with, and ubiquitination of, p21(WAF1). p53RFP appears to represent the second known example, the first being MDM2, of an E3 ubiquitin ligase as a p53 target. Our results further suggest that p53 might regulate the stability of p21(WAF1) through transcriptional regulation of p53RFP, and this feature may represent a novel mechanism for a p53-dependent cell-cycle checkpoint.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, PGM levels were unaffected by either Mdm2 or p53RFP, two ubiquitin ligases that are known to be regulated by p53 (refs. 35, 36; data not shown).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [35]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“GADD45 and a ribonucleotide reductase, p53R2, are involved in DNA repair, whereas p53AIP1, BAX, NOXA, KILLER/DR5, Fas, PIDD and are p53 targets that play significant roles in the p53-inducible apoptotic pathway (Vogelstein et al., 2000).”
BackgroundThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“Among the p53-target genes identified so far, p21WAF1, an inhibitor of cyclin-dependent kinase, is a well-known p53 mediator in arrest of the cell cycle at G1 (Harper et al., 1993).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 1×
“…in the ubiquitination pathway, as many of them have E3 ligase activity or function as essential cofactors of the E3 complex (Jackson et al., 2000; Joazeiro and Weissman, 2000). p53RFP might be the second known example of an E3 ubiquitin ligase as a p53 target (the first being MDM2, a negative…”
BackgroundOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172 · cited 1×
“…a p53-dependent manner as early as 12 h after infection (Figure 1a), but its induction revealed a 6 h delay, compared to that of p21WAF1, suggesting a distinct regulation by the modified p53 between the transcript and p21WAF1 as previously reported in another p53 target, p53AIP1 (Oda et al., 2000).”
ResultSelf-citationMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases
Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., & Reimann, J. D. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01834-1 · Cited by 634
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634
Zhang, Z.-X., Yang, L., Young, K. J., DuTemple, B., & Zhang, L. (2000) · Nature Medicine · doi:10.1038/77513 · Cited by 459 · cited 1×
“Parkin, another molecule with a RING-IBR-RING domain, functions as an E3ubiquitin ligase that binds an E2-ubiquitin-conjugating enzyme, UbcH8, to promote degradation of the synaptic vesicle-associated protein, CDCrel-1 (Zhang et al., 2000).”
Background
Cited by
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Mutual exclusivity analysis identifies oncogenic network modules
Ciriello, G., Cerami, E., Sander, C., & Schultz, N. (2012) · Genome Research · doi:10.1101/gr.125567.111 · Cited by 675
“It negatively regulates p21 (CDKN1A) which itself directly inhibits several cyclin-dependent kinases, including CCNE1 (Ng et al. 2003).”
BackgroundGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Self-citationRBR E3 ubiquitin ligases: new structures, new insights, new questions
Spratt, D. E., Walden, H., & Shaw, G. S. (2014) · Biochemical Journal · doi:10.1042/bj20140006 · Cited by 315
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
Lu, Z., & Hunter, T. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 224
Metadata
- Authors
- Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y.
- Affiliations
- Institute of Medical Science, The University of Tokyo (JP)
- The University of Osaka (JP)
- Corresponding author
- Nakamura, Yusuke
- Venue
- Oncogene
- Published
- 2003-07-10
- Volume
- 22
- Issue
- 28
- Pages
- 4449-4458
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2012650432
- Cited by
- 54
- References
- 27
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 4 · 2020: 1 · 2019: 4 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- p53, p21, protein stability, E3 ubiquitin ligase, ubiquitination, transcription factor target genes, cell cycle checkpoints, tumor suppressor regulation, MDM2
- MeSH terms
- Amino Acid Sequence, Humans, Ligases, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Cyclins, Zinc Fingers, Ubiquitin-Protein Ligases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. https://app.cochat.ai/papers/10.1038/sj.onc.1206586
- The paper
- Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y. (2003). p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene. https://doi.org/10.1038/sj.onc.1206586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.